PROGNOSTIC AND PREDICTIVE GENE SIGNATURE FOR NON-SMALL CELL LUNG CANCER AND ADJUVANT CHEMOTHERAPY
Patent №
US 8,211,643
Granted
2012-07-03
Filed 2009
Owner
UNIVERSITY HEALTH NETWORK
Lab
—
AI components
2
ml · evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
12465954
The application provides methods of prognosing and classifying lung cancer patients into poor survival groups or good survival groups and for determining the benefit of adjuvant chemotherapy by way of a multigene signature. The application also includes kits and computer products for use in the methods of the application.
AI classification
Ownership
UNIVERSITY HEALTH NETWORK
assignment · 231450549
Assignors
TSAO, MING-SOUND, SHEPHERD, FRANCES A., JURISICA, IGOR, DER, SANDY D., STRUMPF, DAN, ZHU, CHANG-QI, SEYMOUR, LESLEY, DING, KEYUE
On an employer assignment, the assignors are typically the inventors.